Clinical recommendations for perioperative immunotherapy-induced adverse events in patients with non-small cell lung cancer.
Ni J, Huang M, Zhang L, Wu N, Bai CX, Chen LA, Liang J, Liu Q, Wang J, Wu YL, Zhang FC, Zhang SY, Chen C, Chen J, Fang WT, Gao SG, Hu J, Jiang T, Li SQ, Li HC, Liao YD, Liu Y, Liu DR, Liu HX, Liu JY, Liu LX, Wang MZ, Wang CL, Yang F, Yang Y, Zhang LJ, Zhi XY, Zhong WZ, Guan YZ, Guo XX, He CX, Li SL, Li Y, Liang NX, Lu FL, Lv C, Lv W, Si XY, Tan FW, Wang HP, Wang JS, Yan S, Yang HX, Zhu HJ, Zhuang JL, Zhuo ML.
Ni J, et al. Among authors: liu hx, liu y, liu q, liu lx, liu dr, liu jy.
Thorac Cancer. 2021 May;12(9):1469-1488. doi: 10.1111/1759-7714.13942. Epub 2021 Mar 30.
Thorac Cancer. 2021.
PMID: 33787090
Free PMC article.